Hepatitis C - Enzo Biochem Shareholders Elect Three Directors at Annual Meeting

Enzo Biochem Shareholders Elect Three Directors at Annual Meeting
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced the election of three directors at the Company's annual meeting today, as well as approval of the Company's 2005 Equity Compensation Incentive Plan. The three Class III directors, each elected to three year

GlobeImmune raises $38M
Denver Business Journal - The Aurora company, a maker of immunotherapy pharmaceuticals called Tarmogens, will use the funding to complete more placebo-controlled clinical trials for its products, GI-4000 and GI-5005. New investors joining the Series B round include PAC-LINK

Adverse effects of, and diseases transmitted by blood transfusion
Manila Bulleting Online - What does the term blood product mean? What are the possible adverse effects and diseases transmitted by blood transfusion? A friend of mine died of cirrhosis of the liver because he received blood that was contaminated with hepatitis B virus when he

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral
Aidsmap - Prolonged high HIV viral loads are associated with an increased risk of non-Hodgkin's lymphoma (NHL) independent of CD4 cell counts, according to data from the French Aquitaine Cohort published in the February 1 st edition of Clinical Infectious

Potential strategy to improve T cell immunotherapy
RxPG - By DFCI, Like boxers wearied by a 15-round bout, the immune system's CD8 T cells eventually become "exhausted" in their battle against persistent viral infection, and less effective in fighting the disease. In a study to be published Dec. 28 on the

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration
RxPG - "The initial success of our efforts to accelerate the HCV clinical trial program for Tarvacin Anti-Viral is gratifying in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C